Sun Pharma Advanced Research Company Reports Strong Sales Growth Amid Rising Interest Costs in March 2025
Sun Pharma Advanced Research Company (SPARC) announced its financial results for the quarter ending March 2025, showcasing significant growth in net sales and improvements in operational efficiency. Despite challenges from rising interest costs, the company achieved its highest profit figures in the last five quarters, indicating a positive trend in its financial performance.
Sun Pharma Advanced Research Company (SPARC) has recently reported its financial results for the quarter ending March 2025, revealing notable trends within its operations. The company recorded net sales of Rs 27.19 crore, reflecting a significant growth compared to the average of Rs 15.29 crore over the previous four quarters. This marks the highest quarterly sales figure for SPARC in the last five quarters, indicating a positive near-term sales trend.In terms of operating profit, SPARC reported its highest figure at Rs -53.18 crore, suggesting an improvement in operational efficiency. The operating profit margin also reached its peak at -195.59%, further indicating a positive shift in the company's efficiency metrics. Additionally, profit before tax and profit after tax figures were the highest recorded in the last five quarters, with values of Rs -60.67 crore and Rs -59.77 crore, respectively.
However, the company faced challenges with rising interest costs, which reached Rs 4.54 crore, the highest in the last five quarters, reflecting increased borrowings. This aspect may warrant attention as it could impact future financial stability.
Overall, SPARC has experienced evaluation changes in its financial score, moving from -12 to -2 over the past three months, highlighting a revision in its assessment.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
